Cerebrospinal fluid biomarkers of AD such as protein tau, phosphorylated tau and amyloid beta 1–42 (Aβ1–42) are also recognized as being supportive features in the diagnosis of PCA [16, 17]. The gene discussed is MAPT; the disease is Alzheimer disease.